DMT-2'-O-MOE-G(iBu)-CE-Phosphoramidite

N2-isobutyryl-5'-O-(4, 4'-dimethoxytrityl)-2'-O- methoxyethyl-guanosine-3'-cyanoethyl Phosphoramidite
Catalog No. PR2-006
CAS No. 251647-55-9
Purity HPLC≥98.0%
Molecular Formula C47H60N7O10P
Molecular Weight 914.01
Storage Condition -20℃

DMT-2'-O-MOE-G(iBu)-CE-Phosphoramidite

N2-isobutyryl-5'-O-(4, 4'-dimethoxytrityl)-2'-O- methoxyethyl-guanosine-3'-cyanoethyl Phosphoramidite
Grade
Amount/Package: 0.25g / 30mL screwed bottle-28
SKU: PR2-006-025A  |  suitable for  MerMade
Collections:  2'-O-MOE Phosphoramidites Oligo Synthesis Phosphoramidites Synthesis Blocks
Unit price:
$15.00

Price

$15.00
Shipping calculated at checkout.
This variant is unavailable. Contact us if you have particular requirements.
Checkout

This variant only support customization. Click the Inquiry button below to submit your custom request to us.

Price/Order Inquiry

Shipping notes
Products on this site:
Currently ship to United States & Canada.
For shipping worldwide, please contact us.
Processment: within 2 business days, if available.
US: 2-8 days (from CA by FedEx).
Canada: 5-10 days (excludes customs delays).

Related Products

Details

DMT-2'-O-MOE-G(iBu)-CE-Phosphoramidite is a 2'-MOE phosphoramidite monomer used for solid-phase oligonucleotide synthesis. It contains a 5'-dimethoxytrityl (DMT) protecting group for 5'-hydroxyl protection, a isobutyryl (iBu) base-protecting group on guanine, a cyanoethyl (CE) protecting group on phosphite, and a 2'-O-methoxyethyl (MOE) modification.

2'-O-MOE provide enhanced nuclease resistance, duplex stability, and low cytotoxicity compared with unmodified RNA.

Structurally, the 2'-hydroxyl group of ribose is replaced by a –O–CH₂–CH₂–O–CH₃ (methoxyethyl) group, which locks the sugar into an RNA-like C3'-endo conformation and stabilizes hybrid formation with complementary RNA strands.

Applications

RNase H-dependent antisense oligonucleotides (ASO)

Often as 2'-O-MOE/DNA chimeras that activate RNase H-mediated cleavage of target RNA.[1]

Steric-blocking ASO

Physically obstructing access to specific RNA molecules, rather than causing their degradation, e.g., splice-switching ASO.[1]

Enzyme or structural RNA inhibition

Inhibit specific RNAs or enzymes (e.g., telomerase) through binding interference.[2]

Features and Benefits

High coupling efficiency and reproducibility in solid-phase DNA synthesis
High purity (≥ 98%) and tightly controlled impurity profiles
Compatible with standard DNA/RNA phosphoramidites
Simplified purification: no special precautions needed against RNase degradation
Fast-deprotection variants available upon request

Other Notes

  • Storage: Store in a dry, inert atmosphere at -20 °C.
  • Coupling: 6 minute coupling time recommended
  • Recommended deprotection: 8 h at 55 °C in concentrated ammonia, or 10 min at 65 °C in AMA (ammonia/methylamine, 1:1 v/v)
  • Compatibility: Can be used alongside modified phosphoramidites (e.g., 2′-OMe, 2′-MOE, Locked-NA) to synthesize chimeric oligonucleotides.

Reference

[1] Hill, Alyssa C., and Jonathan Hall. "The MOE modification of RNA: Origins and widescale impact on the oligonucleotide therapeutics field." Helvetica Chimica Acta 106, no. 3 (2023): e202200169.
[2] Elayadi, Anissa N., Andrea Demieville, Edward V. Wancewicz, Brett P. Monia, and David R. Corey. "Inhibition of telomerase by 2′-O-(2-methoxyethyl) RNA oligomers: effect of length, phosphorothioate substitution and time inside cells." Nucleic Acids Research 29, no. 8 (2001): 1683-1689.

Specifications
  • Catalog No.
    PR2-006
  • CAS No.
    251647-55-9
  • SMILES
    CC(C)N(C(C)C)P(OCCC#N)O[C@H]1[C@@H](OCCOC)[C@H](N(C=N2)C3=C2C(NC(NC(C(C)C)=O)=N3)=O)O[C@@H]1COC(C4=CC=C(OC)C=C4)(C5=CC=CC=C5)C6=CC=C(OC)C=C6
  • Molecular Formula
    C47H60N7O10P
  • Molecular Weight
    914.01
  • Appearance
    White to off-white powder
  • Purity
    HPLC≥98.0%
  • Storage Condition
    -20℃
  • Moisture Content
    K.F.≤0.30% w/w

Documentation
COA Contact Us

DMT-2'-O-MOE-G(iBu)-CE-Phosphoramidite is a 2'-MOE phosphoramidite monomer used for solid-phase oligonucleotide synthesis. It contains a 5'-dimethoxytrityl (DMT) protecting group for 5'-hydroxyl protection, a isobutyryl (iBu) base-protecting group on guanine, a cyanoethyl (CE) protecting group on phosphite, and a 2'-O-methoxyethyl (MOE) modification.

2'-O-MOE provide enhanced nuclease resistance, duplex stability, and low cytotoxicity compared with unmodified RNA.

Structurally, the 2'-hydroxyl group of ribose is replaced by a –O–CH₂–CH₂–O–CH₃ (methoxyethyl) group, which locks the sugar into an RNA-like C3'-endo conformation and stabilizes hybrid formation with complementary RNA strands.

Applications

RNase H-dependent antisense oligonucleotides (ASO)

Often as 2'-O-MOE/DNA chimeras that activate RNase H-mediated cleavage of target RNA.[1]

Steric-blocking ASO

Physically obstructing access to specific RNA molecules, rather than causing their degradation, e.g., splice-switching ASO.[1]

Enzyme or structural RNA inhibition

Inhibit specific RNAs or enzymes (e.g., telomerase) through binding interference.[2]

Features and Benefits

High coupling efficiency and reproducibility in solid-phase DNA synthesis
High purity (≥ 98%) and tightly controlled impurity profiles
Compatible with standard DNA/RNA phosphoramidites
Simplified purification: no special precautions needed against RNase degradation
Fast-deprotection variants available upon request

Other Notes

  • Storage: Store in a dry, inert atmosphere at -20 °C.
  • Coupling: 6 minute coupling time recommended
  • Recommended deprotection: 8 h at 55 °C in concentrated ammonia, or 10 min at 65 °C in AMA (ammonia/methylamine, 1:1 v/v)
  • Compatibility: Can be used alongside modified phosphoramidites (e.g., 2′-OMe, 2′-MOE, Locked-NA) to synthesize chimeric oligonucleotides.

Reference

[1] Hill, Alyssa C., and Jonathan Hall. "The MOE modification of RNA: Origins and widescale impact on the oligonucleotide therapeutics field." Helvetica Chimica Acta 106, no. 3 (2023): e202200169.
[2] Elayadi, Anissa N., Andrea Demieville, Edward V. Wancewicz, Brett P. Monia, and David R. Corey. "Inhibition of telomerase by 2′-O-(2-methoxyethyl) RNA oligomers: effect of length, phosphorothioate substitution and time inside cells." Nucleic Acids Research 29, no. 8 (2001): 1683-1689.

Why choose Hongene?

Trusted Partner in Nucleic Acid

Integrated Supply & Commercial Scale

With 26+ years of expertise, we control a secure supply chain for RNA raw materials and provide reliable GMP-grade oligo synthesis from research to commercial kilogram-scale production.

Proprietary Technology & IP

Our proprietary Chemoenzymatic Ligation Platform combines chemical andenzymatic methods, enabling high-putity, cost-effective, and large-scale production of RNA-based therapeutics.

Rigorous Quality

We implement multiple stringent QC steps, maintain ISO certifications, and ensure >99% batch-to-batch consistency, reducing scale-up and PPQ risks.

Manufacturing Scalability

Hongene operates 1.67 million sq. ft Oligonucleotide Manufacturing Facility, with advanced equipments including multiple OligoPilot™ and OligoProcess™ synthesizers (10-1800 mmol). 48 flexible production lines enable one-stop seamless scaling-up of API production from gram-level to tons and acheive high purity of 98%, meeting NMPA, FDA, and EMA standards.

Global Business Network

Our products and services reach over 40 countries and regions, supporting around 3,000 clients worldwide.

Global Business Distribution
40+
Countries & Regions
3000≈
Global Clients
54000+L
Annual NTP Production
58+t
Annual Amidites Production

Ask us anything!

Back to top

My Wishlist